ONFI |
H-4723 |
CLOBAZAM |
URBANYL |
FRISIUM |
PERIZAM |
HR-376 |
NSC-336279 |
SYMPAZAN |
TAPCLOB |
LM-2717 |
URBANOL |
7-CHLORO-1-METHYL-5-PHENYL-1,5-DIHYDRO-BENZO[B][1,4]DIAZEPINE-2,4-DIONE |
CLOBAZAMUM |
1-PHENYL-5-METHYL-8-CHLORO-1,2,4,5-TETRAHYDRO-2,4-DIOXO-3H-1,5-BENZODIAZEPINE |
drugbank:00349 |
pubchem.compound:2789 |
chembl:CHEMBL70418 |
chemidplus:22316-47-8 |
rxcui:21241 |
Year of Approval | 1975 |
Drug Class | anticonvulsants |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | anxiolytic,anticonvulsant |
n/a |
Trial Name | Clobazam |
Novel drug target | Established target |
n/a |
Novel drug target | Established target |
Trial Name | Clobazam |
ligand |
positive modulator (activating) |
Novel drug target | Established target |
Trial Name | Clobazam |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
n/a |
Trial Name | Clobazam |
Novel drug target | Established target |
positive modulator (activating) |
Trial Name | Clobazam |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Trial Name | Clobazam |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Trial Name | Clobazam |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Trial Name | Clobazam |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Novel drug target | Established target |
Trial Name | Clobazam |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | Clobazam |
positive modulator (activating) |
Trial Name | Clobazam |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Trial Name | Clobazam |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Trial Name | Clobazam |
positive modulator (activating) |
Trial Name | Clobazam |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Trial Name | Clobazam |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Novel drug target | Established target |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | Clobazam |
positive modulator (activating) |
Novel drug target | Established target |
Trial Name | Clobazam |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
CLOBAZAM | Primary Drug Name |
Drug Class | anticonvulsants |
Year of Approval | 1975 |
Drug Indications | anxiolytic,anticonvulsant |
Drug Class | Small Molecule |
FDA Approval | approved |